The influences of adherence to tamoxifen and CYP2D6 pharmacogenetics on plasma concentrations of the active metabolite (Z)-Endoxifen in breast cancer

Nardin, Jeanine Marie; Schroth, Werner; Almeida, Thais Abreu; Picolotto, Solane; Lima Vendramini, Evelyn Castillo; Hoppe, Reiner; Kogin, Jenifer Primon; Miqueleto, Diandra; Robaskievicz de Moraes, Silvia Dark; Schwab, Matthias; Pecoits-Filho, Roberto Flavio; Brauch, Hiltrud; Casali-da-Rocha, Jose Claudio; Mürdter, Thomas E.

The influences of adherence to tamoxifen and CYP2D6 pharmacogenetics on plasma concentrations of the active metabolite (Z)-Endoxifen in breast cancer

Autor(en):

Nardin, Jeanine Marie; Schroth, Werner; Almeida, Thais Abreu; Picolotto, Solane; Lima Vendramini, Evelyn Castillo; Hoppe, Reiner; Kogin, Jenifer Primon; Miqueleto, Diandra; Robaskievicz de Moraes, Silvia Dark; Schwab, Matthias; Pecoits-Filho, Roberto Flavio; Brauch, Hiltrud; Casali-da-Rocha, Jose Claudio; Mürdter, Thomas E.

Tübinger Autor(en):

Schroth, Werner
Hoppe, Reiner
Schwab, Matthias
Brauch, Hiltrud
Mürdter, Thomas E.

Erschienen in:

Cts - Clinical and Translational Science (2019), Bd. 13, H. 2, S. 284-292

Verlagsangabe:

Wiley

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1111/cts.12707

ISSN:

1752-8062